Tag: Armin Ghobadi May 30, 2025 Innovative immunotherapy shows promise against aggressive T cell cancersWashU startup’s “off-the-shelf” CAR-T cell therapy evaluated in international clinical trial.News Release January 14, 2025 New cellular immunotherapy approach shows promise for B-cell lymphomaOff-the-shelf CAR-natural killer cells could expand accessibility, reduce cost of cell-based cancer therapies.News Release December 16, 2024 $10.8 million grant supports cutting-edge leukemia researchNIH renews prestigious program for blood cancer research at WashU Medicine.News Release November 22, 2024 World leaders in ending blood cancerThe Siteman Blood Cancer Center, which brings together the multidisciplinary expertise of WashU Medicine physicians, has long been at the forefront of transforming care. .Outlook Magazine September 1, 2022 Simple blood test may predict neurotoxic complications of CAR-T cell therapyIdentifying high-risk patients could improve cancer care.News Release October 18, 2017 New gene-altering treatment offered for certain blood cancersCAR-T immunotherapy may help patients who don’t respond to standard treatments.News Release, Video Posts navigation
